Metraipolis › archive › dc_2f6a353ffa07

Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in… — Europe PMC PMID:41618370

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41618370
DOI
10.1186/s42358-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-06T10:13:14.248Z
SHA-256 of the archived text
6d6a01fd865aaaf95841f701e9ed0e2cfa4ed8ec7e37e77cafbbea04beb33a5a
Stable URL of this page
https://metraipolis.com/documento/dc_2f6a353ffa07

How to cite

Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in… — Europe PMC PMID:41618370 — Europe PMC (en), https://europepmc.org/article/MED/41618370 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f6a353ffa07 (Metraipolis archive dc_2f6a353ffa07, sha256 6d6a01fd865aaaf95841f701e9ed0e2cfa4ed8ec7e37e77cafbbea04beb33a5a)
BibTeX
@misc{dc2f6a353ffa07,
  title = {Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in… — Europe PMC PMID:41618370},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41618370},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f6a353ffa07; sha256 6d6a01fd865aaaf95841f701e9ed0e2cfa4ed8ec7e37e77cafbbea04beb33a5a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41618370. Agents can read the archived copy with the MCP tool read_document.